Boidot R - Search Results

1

Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen.

Limagne E, Euvrard R, Thibaudin M, Rébé C, Derangère V, Chevriaux A, Boidot R, Végran F, Bonnefoy N, Vincent J, Bengrine-Lefevre L, Ladoire S, Delmas D, Apetoh L, Ghiringhelli F. Limagne E, et al. Among authors: boidot r. Cancer Res. 2016 Sep 15;76(18):5241-52. doi: 10.1158/0008-5472.CAN-15-3164. Epub 2016 Aug 5. Cancer Res. 2016. PMID: 27496709 Clinical Trial.

2

[Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].

Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S. Vegran F, et al. Among authors: boidot r. Bull Cancer. 2005 Mar;92(3):219-26. Bull Cancer. 2005. PMID: 15820916 Free article. Review. French.

3

Distinct expression of Survivin splice variants in breast carcinomas.

Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S. Vegran F, et al. Among authors: boidot r. Int J Oncol. 2005 Oct;27(4):1151-7. Int J Oncol. 2005. PMID: 16142334

4

Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.

Végran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S. Végran F, et al. Among authors: boidot r. Oncogene. 2007 Jan 11;26(2):290-7. doi: 10.1038/sj.onc.1209784. Epub 2006 Jul 17. Oncogene. 2007. PMID: 16847456

5

Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy.

Végran F, Boidot R, Oudin C, Riedinger JM, Bonnetain F, Lizard-Nacol S. Végran F, et al. Among authors: boidot r. Clin Cancer Res. 2006 Oct 1;12(19):5794-800. doi: 10.1158/1078-0432.CCR-06-0725. Clin Cancer Res. 2006. PMID: 17020986

6

Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy.

Oudin C, Bonnetain F, Boidot R, Végran F, Soubeyrand MS, Arnould L, Riedinger JM, Lizard-Nacol S. Oudin C, et al. Among authors: boidot r. Int J Oncol. 2007 May;30(5):1145-51. Int J Oncol. 2007. PMID: 17390016

7

The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas.

Boidot R, Vegran F, Jacob D, Chevrier S, Gangneux N, Taboureau J, Oudin C, Rainville V, Mercier L, Lizard-Nacol S. Boidot R, et al. Genes Chromosomes Cancer. 2008 Apr;47(4):299-308. doi: 10.1002/gcc.20533. Genes Chromosomes Cancer. 2008. PMID: 18181175

8

Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.

Boidot R, Vegran F, Lizard-Nacol S. Boidot R, et al. Int J Mol Med. 2009 Feb;23(2):285-91. Int J Mol Med. 2009. PMID: 19148555

9

Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma.

Boidot R, Vegran F, Soubeyrand MS, Fumoleau P, Coudert B, Lizard-Nacol S. Boidot R, et al. Cancer Invest. 2009 Jun;27(5):521-8. doi: 10.1080/07357900802298096. Cancer Invest. 2009. PMID: 19479487 Clinical Trial.

10

Gene expression profile and response to trastuzumab-docetaxel-based treatment in breast carcinoma.

Végran F, Boidot R, Coudert B, Fumoleau P, Arnould L, Garnier J, Causeret S, Fraise J, Dembélé D, Lizard-Nacol S. Végran F, et al. Among authors: boidot r. Br J Cancer. 2009 Oct 20;101(8):1357-64. doi: 10.1038/sj.bjc.6605310. Epub 2009 Sep 15. Br J Cancer. 2009. PMID: 19755993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters